Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory
Rattachement africain : it, au, ca. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
INTRODUCTION: Diabetes is a highly prevalent disease worldwide and represents a challenge for patients and healthcare systems. This population-based study evaluated diabetes burden in Italy in 2018 by assessing all aspects of outpatient and hospital care. RESEARCH DESIGN AND METHODS: We investigated data of 11 300 750 residents in local health districts contributing to ARNO Diabetes Observatory (~20% of Italian inhabitants). All administrative healthcare claims were analyzed to gather information on access to medical resources. Subjects with diabetes, identified by antihyperglycemic drug prescriptions, disease-specific copayment exemption and hospital discharge codes, were compared with age, sex and residency-matched non-diabetic individuals. RESULTS: We identified 697 208 subjects with ascertained diabetes, yielding a prevalence of 6.2% (6.5% in men vs 5.9% in women, p<0.001). Age was 69±15 (mean±SD). As compared with non-diabetic subjects, patients with diabetes received more prescriptions of any drugs (+30%, p<0.001), laboratory tests, radiologic exams and outpatient specialist consultations (+20%, p<0.001) and were hospitalized more frequently (+86%, p<0.001), with a longer stay (+1.4 days, p<0.001). Although cardiovascular diseases accounted for many hospital discharge diagnoses, virtually all diseases contributed to the higher rate of hospital admissions in diabetic subjects (235 vs 99 per 1000 person-years, p<0.001). Healthcare costs were >2-fold higher in subjects with diabetes, mainly driven by hospitalizations and outpatient care related to chronic complications rather than to glucose-lowering drugs, diabetes-specific devices, or metabolic monitoring. CONCLUSIONS: The burden of diabetes in Italy is particularly heavy and, as a systemic disease, it includes all aspects of clinical medicine, with consequent high expenses in all areas of healthcare.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory
- Date Crossref
- 01/07/2020
- Éditeur
- BMJ
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Verona Department of Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Diabetes Australia pays non établi dans la noticeOrganisation à but non lucratif
-
Cineca pays non établi dans la noticeInstitution
-
University of Bologna Internal Medicine and Gastroenterology pays non établi dans la noticeUniversité ou école supérieure
-
University of Pisa Diabetes and Metabolism pays non établi dans la noticeUniversité ou école supérieure
-
University of Naples Federico II Department of Clinical and Experimental Medicine pays non établi dans la noticeUniversité ou école supérieure
-
University of Padua Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Health Research Foundation pays non établi dans la noticeOrganisation à but non lucratif
-
Division of Endocrinology pays non établi dans la noticeInstitution
-
Internal Medicine and Gastroenterology pays non établi dans la noticeInstitution
-
Diabetes and Metabolism pays non établi dans la noticeInstitution
-
Department of Clinical and Experimental Medicine pays non établi dans la noticeÉtablissement de santé
Department of Medicine — University of Verona, Diabetes Australia et Cineca, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.